Answers are grounded in this paper and cite their sources.
Depression affects more than one-third of patients with diarrhea-predominant irritable bowel syndrome (IBS-D), yet the gut-brain mechanisms remain poorly understood. Here, we identified enrichment of Bacteroides fragilis in IBS-D patients with comorbid depression, with relative abundance positively correlating with Hamilton Depression Rating Scale scores. B. fragilis exposure induced depressive-like behaviors in antibiotic-treated and germ-free mice and was accompanied by reduced hippocampal sphingomyelin phosphodiesterase 4 (SMPD4), altered myelin-associated gene programs, and myelin loss. A combined hippocampal rescue strategy using Syn- and MBP-promoter AAV vectors restored SMPD4 expression and improved behavioral and myelin-related outcomes. B. fragilis cultures and a C1P-producing engineered bacterial strain supported an association between bacterial sphingolipid production and the phenotype, whereas peripheral C1P administration increased hippocampal C1P and reduced SMPD4 and myelin markers. Dietary branched-chain amino acid restriction reduced systemic C1P-associated signals, restored SMPD4 expression, and partially improved depressive-like phenotypes. Collectively, the findings support a B. fragilis-associated C1P-SMPD4 pathway linking intestinal dysbiosis to hippocampal sphingolipid imbalance and myelin disruption, while leaving the route and molecular form by which peripheral lipid signals influence the brain unresolved.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: